Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
Biotech
Cell & Gene Therapy
Clinical Data
Venture Capital
Deals
Research
Medtech
Devices
Diagnostics
AI and Machine Learning
CRO
Special Reports
Trending Topics
Clinical Development
Biologics
Fierce 50
Special Report
Awards Gala
Resources
Fierce Events
Industry Events
Webinars
Podcasts
Whitepapers
Survey
Events
Subscribe
Trending T
Biotech
Cell & Gene Therapy
Clinical Data
Venture Capital
Deals
Research
Medtech
Devices
Diagnostics
AI and Machine Learning
CRO
Special Reports
Trending Topics
Clinical Development
Biologics
Fierce 50
Special Report
Awards Gala
Resources
Fierce Events
Industry Events
Webinars
Podcasts
Whitepapers
Survey
Events
Subscribe
Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
Daiichi Sankyo
Biotech
AstraZeneca, Daiichi share data behind Dato-DXd do-over
The partners showed subgroup overall survival data that exceeded the result seen in the broader population, providing evidence to support the pivot.
Nick Paul Taylor
Dec 6, 2024 5:21am
AstraZeneca, Daiichi pull lung cancer BLA for Enhertu follow-up
Nov 12, 2024 5:27am
Merck KGaA tumor trial hits goal, teeing up Daiichi, Ono rivalry
Nov 12, 2024 4:46am
AstraZeneca, Daiichi ADC fails to improve breast cancer survival
Sep 23, 2024 7:23am
Merck, Daiichi ADC hits goal in phase 3 lung cancer study
Sep 17, 2024 7:13am
AstraZeneca, Daiichi unpack Dato-DXd's overall survival fail
Sep 10, 2024 6:00am
